Tops & Flops Stocks
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 1.630% | 2.218% | 0.769% | -8.995% | -4.085% | -13.994% | -20.314% |
Takara Bio Inc. | 0.770% | 5.645% | 14.912% | -37.619% | -14.935% | -69.393% | -61.919% |
Tactile Systems Technology Inc | 1.790% | 9.615% | 6.542% | -49.107% | -11.628% | -70.619% | - |
Tabula Rasa HealthCare Inc | -1.520% | - | - | - | - | - | - |
T2 Biosystems Inc. | -44.060% | - | - | - | - | - | - |
Sysmex Corp. | - | 1.418% | -2.055% | -75.345% | -70.697% | -85.408% | -76.167% |
Syros Pharmaceuticals Inc. | 6.190% | 15.385% | 12.150% | 90.476% | -9.091% | -85.000% | - |
Synthetic Biologics Inc. | -0.380% | 16.743% | 11.623% | -58.618% | -36.375% | -93.969% | -95.300% |
Synergy Pharmaceuticals | - | - | - | - | - | - | - |
Syndax Pharmaceuticals Inc | -3.510% | 3.810% | 15.957% | 11.795% | 16.578% | 57.971% | - |
Synairgen plc | -3.600% | 0.943% | -17.054% | -30.339% | -17.565% | -96.953% | -42.473% |
Swedish Orphan Biovitrum Ab | -1.660% | -5.542% | -2.568% | 31.470% | -2.568% | 52.926% | 18.758% |
Sutro Biopharma Inc | -3.160% | 12.883% | 18.710% | -13.615% | -5.155% | -74.795% | - |
Sustainable Nutrition Group Ltd. | - | - | - | - | - | - | - |
Surgery Partners Inc | 5.510% | 24.074% | 14.530% | -31.633% | -6.944% | -45.082% | 306.061% |
Surgalign Holdings Inc. | -39.530% | - | - | - | - | - | - |
Super Sonic Imagine | 0.680% | - | - | - | - | - | - |
Supernus Pharmaceuticals | - | 7.317% | 7.317% | 1.538% | 0.763% | 20.000% | -7.042% |
Super League Gaming Inc | -6.540% | - | - | - | - | - | - |
Summit Therapeutics plc | -33.450% | - | - | - | - | - | - |
Stryker Corp. | 0.130% | -1.766% | -4.762% | 15.211% | 13.417% | 40.238% | 64.622% |
Strongbridge Biopharma plc | 0.590% | - | - | - | - | - | - |
Stratec SE | -4.630% | -4.059% | -9.660% | -30.016% | -7.298% | -64.423% | -21.058% |
Strata Skin Sciences Inc. | 24.500% | - | - | - | - | - | - |
Stoke Therapeutics Inc | 5.690% | 4.032% | -11.034% | - | - | - | - |